Preserving the effectiveness of antibiotics

JAMA

Volumn 303, Issue 22, 2010, Pages 2293-2294

  Gaynes, Robert P ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; LINEZOLID; PENICILLIN G; TELAVANCIN; VANCOMYCIN; ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; OXAZOLIDINONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTEREMIA; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; CFR GENE; DRUG EFFICACY; DRUG RESEARCH; DRUG TOLERABILITY; DRUG USE; EDITORIAL; ENTEROBACTERIACEAE; ENTEROCOCCUS; HEALTH CARE COST; HEALTH CARE QUALITY; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR CLONING; MORTALITY; MULTIDRUG RESISTANCE; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS; STAPHYLOCOCCUS INFECTION; THROMBOCYTOPENIA; VENTILATOR ASSOCIATED PNEUMONIA; CLINICAL PRACTICE; NOTE;

ACETAMIDES; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, MICROBIAL; HUMANS; INFECTION CONTROL; OXAZOLIDINONES; PHYSICIAN'S PRACTICE PATTERNS; STAPHYLOCOCCAL INFECTIONS;

EID: 77953282313     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.766     Document Type: Editorial

References (15)

1. Sánchez García M, De la Torre MA, Morales G, et al. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. JAMA. 2010;303(22):2260-2264.
2. Wang G, Hindler JF, Ward KW, Bruckner DA. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J Clin Microbiol. 2006;44(11):3883-3886.
3. Beekmann SE, Gilbert DN, Polgreen PM; Infectious Disease Society of America Emerging Infections Network. Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America emerging infections network survey. Diagn Microbiol Infect Dis. 2008;62(4):407-410.
4. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol. 2005;26(2):166-174.
5. Hidron AI, Edwards JR, Patel J, et al; National Healthcare Safety Network Team; Participating National Healthcare Safety Network Facilities. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008;29(11):996-1011.
6. Livermore DM. Has the era of untreatable infections arrived? J Antimicrob Chemother. 2009;64(suppl 1):i29-i36.
7. World Health Organization. WHO Global Strategy for Containment of Antimicrobial Resistance. Geneva, Switzerland: World Health Organization; 2001.
8. Infectious Diseases Society of America. The 10 x '20 initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clin Infect Dis. 2010;50(8):1081-1083.
9. Tacconelli E, De Angelis G, Cataldo MA, Pozzi E, Cauda R. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? a systematic review and meta-analysis. J Antimicrob Chemother. 2008;61(1):26-38.
10. Rahal JJ, Urban C, Horn D, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA. 1998;280(14):1233-1237.
11. Harbarth S, Cosgrove S, Carmeli Y. Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother. 2002;46(6):1619-1628.
12. Rahal JJ, Urban C, Segal-Maurer S. Nosocomial antibiotic resistance in multiple Gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites. Clin Infect Dis. 2002;34(4):499-503.
13. de Man P, Verhoeven BA, Verbrugh HA, Vos MC, van den Anker JN. An antibiotic policy to prevent emergence of resistant bacilli. Lancet. 2000;355(9208):973-978.
14. Arnold FW, McDonald LC, Smith RS, Newman D, Ramirez JA. Improving antimicrobial use in the hospital setting by providing usage feedback to prescribing physicians. Infect Control Hosp Epidemiol. 2006;27(4):378-382.
15. Wachter RM, Flanders SA, Fee C, Pronovost PJ. Public reporting of antibiotic timing in patients with pneumonia: lessons from a flawed performance measure. Ann Intern Med. 2008;149(1):29-32.